Lineage Cell Therapeutics (LCTX) director granted 125,000 options at $1.30 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lineage Cell Therapeutics director Dipti Amin received a stock option grant covering 125,000 common shares. The option has an exercise price of $1.30 per share and expires on July 1, 2036. It will vest and become exercisable on the earlier of July 1, 2027 and the date of the company’s next annual shareholder meeting, subject to Amin’s continuous service. Following this grant, Amin holds options for 125,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Amin Dipti
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 125,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 125,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 125,000 options
Exercise price: $1.30 per share
Underlying shares: 125,000 shares
+3 more
6 metrics
Option grant size
125,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$1.30 per share
Fixed price to buy Lineage common shares
Underlying shares
125,000 shares
Common shares subject to the option
Post-grant holdings (options)
125,000 options
Total derivative holdings following transaction
Vesting date trigger
Earlier of July 1, 2027 or next annual meeting
Subject to continuous service condition
Expiration date
July 1, 2036
Last date to exercise the options
Key Terms
Stock Option (Right to Buy), exercise price, vest and become exercisable, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "1.3000" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"Will vest and become exercisable on the earlier of July 1, 2027..."
expiration date financial
"expiration_date: "2036-07-01T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Shares""
FAQ
What did Lineage Cell Therapeutics (LCTX) director Dipti Amin receive in this Form 4?
Director Dipti Amin received a stock option grant for 125,000 common shares. The option is a compensation-related award, not an open-market purchase, and gives the right to buy shares at a fixed exercise price in the future.
What is the exercise price of Dipti Amin’s stock options in LCTX?
The stock options have an exercise price of $1.30 per share. This is the fixed price at which Amin can buy Lineage Cell Therapeutics common shares once the options vest and become exercisable, regardless of the market price at that time.
When do Dipti Amin’s Lineage Cell Therapeutics options vest and become exercisable?
The options vest on the earlier of July 1, 2027 and the date of Lineage Cell Therapeutics’ next annual shareholder meeting. Vesting is also conditioned on Amin’s continuous service with the company through the applicable vesting date.
What is the expiration date of Dipti Amin’s LCTX stock option grant?
The stock option grant expires on July 1, 2036. After this expiration date, any unexercised portion of the 125,000 options will lapse, and Amin will no longer have the right to purchase those shares at the stated exercise price.